JP2017500057A5 - - Google Patents

Info

Publication number

JP2017500057A5

JP2017500057A5 JP2016553248A JP2016553248A JP2017500057A5 JP 2017500057 A5 JP2017500057 A5 JP 2017500057A5 JP 2016553248 A JP2016553248 A JP 2016553248A JP 2016553248 A JP2016553248 A JP 2016553248A JP 2017500057 A5 JP2017500057 A5 JP 2017500057A5

Authority

JP

Japan

Prior art keywords

seq

amino acid

acid sequence

set forth

sequence set

Prior art date

2014-11-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 164
• 239000000427 antigen Substances 0.000 claims description 79
• 102000036639 antigens Human genes 0.000 claims description 79
• 108091007433 antigens Proteins 0.000 claims description 79
• 238000000034 method Methods 0.000 claims description 47
• 210000004027 cell Anatomy 0.000 claims description 40
• 206010028980 Neoplasm Diseases 0.000 claims description 38
• 230000005867 T cell response Effects 0.000 claims description 31
• 239000012642 immune effector Substances 0.000 claims description 21
• 229940121354 immunomodulator Drugs 0.000 claims description 21
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 16
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 16
• 239000012634 fragment Substances 0.000 claims description 14
• 230000004936 stimulating effect Effects 0.000 claims description 14
• 201000010099 disease Diseases 0.000 claims description 13
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 12
• 210000003162 effector t lymphocyte Anatomy 0.000 claims description 12
• 210000003071 memory t lymphocyte Anatomy 0.000 claims description 12
• 210000004986 primary T-cell Anatomy 0.000 claims description 12
• 231100000433 cytotoxic Toxicity 0.000 claims description 9
• 230000001472 cytotoxic effect Effects 0.000 claims description 9
• 239000000203 mixture Substances 0.000 claims description 9
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 6
• 150000007523 nucleic acids Chemical class 0.000 claims description 6
• 102000039446 nucleic acids Human genes 0.000 claims description 6
• 108020004707 nucleic acids Proteins 0.000 claims description 6
• 239000008194 pharmaceutical composition Substances 0.000 claims description 6
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 4
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 4
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims description 4
• 101710160107 Outer membrane protein A Proteins 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 206010000830 Acute leukaemia Diseases 0.000 claims description 3
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 3
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 3
• 206010006187 Breast cancer Diseases 0.000 claims description 3
• 208000026310 Breast neoplasm Diseases 0.000 claims description 3
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 3
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 3
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 3
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 3
• 102000003735 Mesothelin Human genes 0.000 claims description 3
• 108090000015 Mesothelin Proteins 0.000 claims description 3
• 206010027406 Mesothelioma Diseases 0.000 claims description 3
• 208000034578 Multiple myelomas Diseases 0.000 claims description 3
• 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims description 3
• 101100155997 Mus musculus Vmn1r51 gene Proteins 0.000 claims description 3
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 3
• 206010033128 Ovarian cancer Diseases 0.000 claims description 3
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
• 206010060862 Prostate cancer Diseases 0.000 claims description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 3
• 101150109474 TMEM37 gene Proteins 0.000 claims description 3
• 201000011510 cancer Diseases 0.000 claims description 3
• 208000024207 chronic leukemia Diseases 0.000 claims description 3
• 208000005017 glioblastoma Diseases 0.000 claims description 3
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims description 2
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 2
• 210000001185 bone marrow Anatomy 0.000 claims description 2
• 210000004556 brain Anatomy 0.000 claims description 2
• 230000000139 costimulatory effect Effects 0.000 claims description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
• 210000004185 liver Anatomy 0.000 claims description 2
• 210000004072 lung Anatomy 0.000 claims description 2
• 210000002540 macrophage Anatomy 0.000 claims description 2
• 210000000952 spleen Anatomy 0.000 claims description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
• 208000025113 myeloid leukemia Diseases 0.000 claims 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• -1 Tert Proteins 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 230000004913 activation Effects 0.000 description 1